Alaya.bio
About:
Polymeric delivery platform for in vivo applications
Website: https://www.alaya.bio/
Description:
Alaya.bio is a pioneering biotechnology company dedicated to advancing in situ gene delivery platform, particularly in the field of CAR T cell immunotherapy. Alaya.bio’s proprietary polymeric delivery nanoparticle offers precise targeting of cells and organs, and enhanced delivery of a wide range of therapeutic payloads, from viral vectors to nucleic acids (incl. mRNA).
Total Funding Amount:
$3M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2022-06-15
Contact Email:
hello(AT)alaya.bio
Founders:
Cécile BAUCHE, Renaud VAILLANT
Number of Employees:
11-50
Last Funding Date:
2022-08-08
IPO Status:
Private
Industries:
© 2025 bioDAO.ai